Research > Focus C > Work Packages C05
Summary
This project aims to explore the potential of particle radiotherapy, i.e., the parameter space, radiation quality, dose, dose-rate and linear energy transfer (LET, ionization density along the track) to overcome glioblastoma treatment resistance by eradicating the radioresistant tumor subpopulations and forming an immune permissive niche via reprograming of the tumor immune microenvironment while optimally sparing normal tissue.
Task 1
Radiobiological optimization of GB therapeutic window with personalized particle RT
Steps / Workflow
Biophysical characterization of radiation response:
- Dose, LET, Dose-rate
- DNA Damage Repair (DDR) Kinetics
- Deciphering the MoA via integrative Omics
- Impelement 3D personalized GB Models
- Develop predictive models for GB response to particle RT parameter space (UNIVERSE)
Task 2
Remodeling GB tumor microtube network with particle RT
Steps / Workflow
- Characterize particle RT effect on formation of complex nonrepairable DNA – damage clusters and their relevance for microtube formation in vivo
- Analyze differential pathways triggered by DDR and their impact on cell survival signals throughout the microtube network
Task 3
Mechanisms of GB resistance at the tumor-stroma interface
Steps / Workflow
- Evaluate the impact of high- LET RT to eradicate radioresistant GB subpopulations forming an immuno-permissive niche
- Spatial deconvolution of TIME response to particle RT at single cell resolution
- Reprogram TIME to synergize with immunogenic effects of high-LET particle RT towards development of novel in-situ tumor vaccination strategies
Task 4
Development of biomarker of GB response to RT
Steps / Workflow
- Integrative omics analysis of tumor evolution under RT
- Optimizing tumor delineation for high precision particle RT
- Longitudinal spatio-temporal tracking of tumor and normal tissue evolution with respect to particle RT dose distribution and quality (biophysical model)
ABDOLLAHI, AMIR, Prof. DR. MED., DR. RER. NAT.
Heidelberg University Hospital, Division of Molecular and Translational Radiation Oncology Heidelberg Ion-Beam Therapy Center (HIT), Im Neuenheimer Feld 450, 69120 Heidelberg, Germany
DOKIC, IVANA, DR. RER. NAT.
Heidelberg University Hospital, Division of Molecular and Translational Radiation Oncology Heidelberg Ion-Beam Therapy Center (HIT), Im Neuenheimer Feld 450, 69120 Heidelberg, Germany
Address
Im Neuenheimer Feld 400
69120 Heidelberg
Themen
Research
- Focus A
- A01: Targeting tumor cell network communication to overcome primary and adaptive resistance in glioblastoma
- A02: Development of a specific combination therapy for histone H3-mutant pediatric glioblastoma
- A03: Deciphering resistance against targeted treatments
- A04: Elucidating tumor-associated microglia interactions in astrocytomas CNS WHO-grade 4
- A05: Predictive biomarkers for MGMT-promoter-methylated glioblastoma (2019 – 2023)
- A06: Resistance mechanisms of glioblastoma against alkylating agents and radiotherapy
- A07: Mapping and targeting neuron-tumor networks to tackle therapy resistance in glioblastoma
- A08: Personalized glioblastoma treatment guided by patient-derived tumor organoids
Research
- Focus B
- B01: Mechanisms of response and resistance to glioma-specific t cells
- B02: DNA mis-match repair regulates immune checkpoint blockade therapy in glioblastoma (2019 – 2023)
- B03: Targeting immunosuppressive programs in isocitrate dehydrogenase mutant gliomas
- B04: Impact of myeloid cells on the adaptive immune response in newly diagnosed and recurrent glioblastomas
- B05: Dissecting the response of glioblastoma and its tumor microenvironment to focused high-dose radiotherapy (2019 – 2023)
- B06: Visualization and characterization of immune responses in H3K27M mutant gliomas
Research
- Focus C
- C01: Comprehensive preclinical pharmacology testing of drugs used for glioblastoma treatment
- C02: Radiomics, radiogenomics and deep-learning in neurooncology
- C03: Imaging immune signatures of glioma response and resistance towards immunotherapy (2019 – 2023)
- C04: Metabolic signaling in glioblastoma: a spatial multi-omics approach
- C05: Overcoming glioma radio-resistance with particle therapy
- C06: Functional characterization of EGFR structural variants associated with long-term survival in glioblastoma, IDH-WT